latest news releases from the newsroom
Medicis Pharmaceutical Corporation
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
SCOTTSDALE, Ariz., May 8, 2006 (PRIMEZONE) -- Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration ("FDA") has approved its New Drug Application ("NDA") for SOLODYN(TM) (minocycline HCl, USP) Extended Release Tablets. SOLODYN(TM) is the only oral minocycline approved for once daily dosage in the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. SOLODYN(TM) is also the only approved minocycline in extended release tablet form. SOLODYN(TM) is lipid soluble, and its mode of action occurs in the skin and sebum. SOLODYN(TM) is not bioequivalent to any other minocycline products, and is in no way interchangeable with other forms of minocycline.
Budget Waste Inc.
Budget Waste Inc. Finalizes the Acquisition of Provac
CALGARY, Alberta, May 8, 2006 (PRIMEZONE) -- BWI (Pink Sheets:BDWT), a premier waste solutions company in the Calgary area, finalizes the acquisition of Provac, a leading liquid waste hauling company. With a reputation as leaders in liquid waste hauling, Provac operates a fleet of 7 late model vehicles providing hydrovac, vacuum, line flushing and pressure washing services to the municipal and oil field markets in Alberta.
WCA Waste Corporation
WCA Waste Corporation Announces First Quarter 2006 Results
HOUSTON, May 8, 2006 (PRIMEZONE) -- WCA Waste Corporation (Nasdaq:WCAA) announced today financial results for the first quarter 2006. For the first quarter 2006, revenue increased 51.5% to $34.7 million over the $22.9 million that was reported for the same period last year. Operating income increased 103.3% to $5.1 million over the $2.5 million that was reported over the quarter ended March 31, 2005. Operating margins increased to 14.8% of revenue versus 11.0% for the same quarter last year. Net income for the quarter was $0.6 million, or $0.04 per share. During the quarter average borrowing costs increased to 8.38% versus 5.06% for the same quarter of 2005. This increase and the incremental interest expense affected net income by $0.05 per share for the first quarter of 2006.
Biogenerics Limited Announces 2nd Grimes Well is Online
TYLER, Texas, May 8, 2006 (PRIMEZONE) -- Biogenerics, Limited (Pink Sheets:BIGN) is pleased to announce that Ophelia 1 is the second of four gas wells to go online from its Grimes property in California. After its initial serge, production reports indicate that, after three weeks in operation, current flow rates for Ophelia 1 have stabilized at 1,450 mcfd.